Modulatory effect of CCK-8S on GABA-induced depolarization from rat dorsal root ganglion

Brain Research

Volumn 1121, Issue 1, 2006, Pages 66-75

  Ma, Ke Tao ^a,b   Si, Jun Qiang ^a,b   Zhang, Zhi Qin ^c   Zhao, Lei ^b   Fan, Ping ^d   Jin, Jin Lan ^b   Li, Xin Zhi ^b   Zhu, Li ^b  

^a WUHAN UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c Jinhua Medical College of Vocation   (China)

^d First Affiliated Hospital   (China)

Author keywords

CCK 8S; DRG; GABA; Intracellular recording; Rat; Sensory information

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 AMINOBUTYRIC ACID; CHELERYTHRINE; CHOLECYSTOKININ OCTAPEPTIDE; ENZYME INHIBITOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; INTRACELLULAR RECORDING; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ACTION POTENTIALS; ANIMALS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GANGLIA, SPINAL; MALE; MEMBRANE POTENTIALS; NEURONS; RATS; RATS, WISTAR; SINCALIDE; SPINAL CORD;

MAMMALIA;

EID: 33750715129     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.094     Document Type: Article

References (52)

1. Andre J., Zeau B., Pohl M., Cesselin F., Benoliel J.J., and Becker C. Involvement of cholecystokininergic systems in anxiety-induced hyperalgesia in male rats: behavioral and biochemical studies. J. Neurosci. 25 (2005) 7896-7904
2. Boden P.R., and Hill R.G. Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitro. Neuropeptides 12 (1988) 95-103
3. Boden P., and Woodruff G.N. Ionic mechanisms underlying cholecystokinin action in rat brain. Ann. N. Y. Acad. Sci. 713 (1994) 129-137
4. Broberger C., Farkas-Szallasi T., Szallasi A., Lundberg J.M., Hokfelt T., Wiesenfeld-Hallin Z., and Xu X.J. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies. Pain 84 (2000) 21-28
5. Cahill C.M., Dray A., and Coderre T.J. Intrathecal nerve growth factor restores opioid effectiveness in an animal model of neuropathic pain. Neuropharmacology 45 (2003) 543-552
6. Cesselin F. Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol. 9 (1995) 409-433
7. Chen Q.X., Stelzer A., Kay A.R., and Wong R.K. GABAA receptor function is regulated by phosphorylation in acutely dissociated guinea-pig hippocampal neurones. J. Physiol. 420 (1990) 207-221
8. Crawley J.N., and Corwin R.L. Biological actions of cholecystokinin. Peptides 15 (1994) 731-755
9. Dauge V., Corringer P.J., and Roques B.P. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101. Pharmacol. Biochem. Behav. 50 (1995) 133-139
10. Day H.E., McKnight A.T., Poat J.A., and Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33 (1994) 719-727
11. De Belleroche J., Bandopadhyay R., King A., Malcolm A.D., O'Brien K., Premi B.P., and Rashid A. Regional distribution of cholecystokinin messenger RNA in rat brain during development: quantitation and correlation with cholecystokinin immunoreactivity. Neuropeptides 15 (1990) 201-212
12. Detjen K., Yule D., Tseng M.J., Williams J.A., and Logsdon C.D. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am. J. Physiol. 273 (1997) C1449-C1457
13. Dockray G.J. Immunochemical evidence of cholecystokinin-like peptides in brain. Nature 264 (1976) 568-570
14. Dodd J., and Kelly J.S. The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus. Brain Res. 205 (1981) 337-350
15. Dun N.J., Wu S.Y., and Lin C.W. Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro. Brain Res. 556 (1991) 161-164
16. Eccles J.C. Presynaptic inhibition in the spinal cord. Prog. Brain Res. 12 (1964) 65-91
17. Ghilardi J.R., Allen C.J., Vigna S.R., McVey D.C., and Mantyh P.W. Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions. J. Neurosci. 12 (1992) 4854-4866
18. Gokin A.P., Hillsley K., and Mawe G.M. Cholecystokinin depolarizes guinea pig sphincter of Oddi neurons by activating CCK-A receptors. Am. J. Physiol. 272 (1997) G1365-G1371
19. Gyenes M., Wang Q., Gibbs T.T., and Farb D.H. Phosphorylation factors control neurotransmitter and neuromodulator actions at the gamma-aminobutyric acid type A receptor. Mol. Pharmacol. 46 (1994) 542-549
20. Huang R.Q., and Dillon G.H. Maintenance of recombinant type A gamma-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin. J. Pharmacol. Exp. Ther. 286 (1998) 243-255
21. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D.C., Hunter J.C., Pinnock R.D., and Woodruff G.N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6728-6732
22. Innis R.B., Correa F.M., Uhl G.R., Schneider B., and Snyder S.H. Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 521-525
23. Katsuura T. Influences of age and sex on cardiac output during submaximal exercise. Ann. Physiol. Anthropol. 5 (1986) 39-57
24. Kolaj M., and Randic M. mu-Opioid receptor-mediated reduction of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-activated current in dorsal horn neurons. Neurosci. Lett. 204 (1996) 133-137
25. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., and Matowe W.C. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro. J. Physiol. 555 (2004) 71-84
26. Liu N.J., Xu T., Xu C., Li C.Q., Yu Y.X., Kang H.G., and Han J.S. Cholecystokinin octapeptide reverses mu-opioid-receptor-mediated inhibition of calcium current in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 275 (1995) 1293-1299
27. McMahon S.B., and Koltzenburg M. Novel classes of nociceptors: beyond Sherrington. Trends Neurosci. 13 (1990) 199-201
28. Mercer L.D., and Beart P.M. Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor. Neurosci. Lett. 225 (1997) 97-100
29. Miyoshi R., Kito S., and Nomoto T. Cholecystokinin increases intracellular Ca2+ concentration in cultured striatal neurons. Neuropeptides 18 (1991) 115-119
30. Nicoll R.A., Schenker C., and Leeman S.E. Substance P as a transmitter candidate. Annu. Rev. Neurosci. 3 (1980) 227-268
31. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology: XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781
32. Si J.Q., Li Z.W., Hu H.Z., Zhou X.P., and Guan B.C. Inhibitory effect of baclofen on GABA-induced depolarization and GABA-activated current in primary sensory neurons. Neuroscience 81 (1997) 821-827
33. Si J.Q., Zhang Z.Q., Li C.X., Wang L.F., Yang Y.L., and Li Z.W. Modulatory effect of substance P on GABA-activated currents from rat dorsal root ganglion. Acta Pharmacol. Sin. 25 (2004) 623-629
34. Skinner K., Basbaum A.I., and Fields H.L. Cholecystokinin and enkephalin in brain stem pain modulating circuits. NeuroReport 8 (1997) 2995-2998
35. Stanfa L., Dickenson A., Xu X.J., and Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol. Sci. 15 (1994) 65-66
36. Tsujino N., Yamanaka A., Ichiki K., Muraki Y., Kilduff T.S., Yagami K., Takahashi S., Goto K., and Sakurai T. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J. Neurosci. 25 (2005) 7459-7469
37. Vanderhaeghen J.J., Signeau J.C., and Gepts W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257 (1975) 604-605
38. Verge V.M., Wiesenfeld-Hallin Z., and Hokfelt T. Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey. Eur. J. Neurosci. 5 (1993) 240-250
39. Wang X.J., and Han J.S. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors. J. Neurochem. 55 (1990) 1379-1382
40. Wang R.A., and Randic M. Activation of mu-opioid receptor modulates GABAA receptor-mediated currents in isolated spinal dorsal horn neurons. Neurosci. Lett. 180 (1994) 109-113
41. Wang X.J., Fan S.G., Ren M.F., and Han J.S. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors. Life Sci. 45 (1989) 117-123
42. Wang L., Martinez V., Barrachina M.D., and Tache Y. Fos expression in the brain induced by peripheral injection of CCK or leptin plus CCK in fasted lean mice. Brain Res. 791 (1998) 157-166
43. Wank S.A. G protein-coupled receptors in gastrointestinal physiology: I. CCK receptors: an exemplary family. Am. J. Physiol. 274 (1998) G607-G613
44. Wiesenfeld-Hallin Z., and Xu X.J. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Regul. Pept. 65 (1996) 23-28
45. Wiesenfeld-Hallin Z., Xu X.J., Hughes J., Horwell D.C., and Hokfelt T. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 7105-7109
46. Xu X.J., Puke M.J., Verge V.M., Wiesenfeld-Hallin Z., Hughes J., and Hokfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat. Neurosci. Lett. 152 (1993) 129-132
47. Yamada K., and Akasu T. Substance P suppresses GABAA receptor function via protein kinase C in primary sensory neurones of bullfrogs. J. Physiol. 496 Pt 2 (1996) 439-449
48. Yule D.I., Tseng M.J., Williams J.A., and Logdson C.D. A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists. Am. J. Physiol. 265 (1993) G999-G1004
49. Yule D.I., Baker C.W., and Williams J.A. Calcium signaling in rat pancreatic acinar cells: a role for Galphaq, Galpha11, and Galpha14. Am. J. Physiol. 276 (1999) G271-G279
50. Zhang X., Dagerlind A., Elde R.P., Castel M.N., Broberger C., Wiesenfeld-Hallin Z., and Hokfelt T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience 57 (1993) 227-233
51. Zhang W., Segura B.J., and Mulholland M.W. Cholecystokinin-8 induces intracellular calcium signaling in cultured myenteric neurons from neonatal guinea pigs. Peptides 23 (2002) 1793-1801
52. Zheng Z., Lewis M.W., and Travagli R.A. In vitro analysis of the effects of cholecystokinin on rat brain stem motoneurons. Am. J. Physiol.: Gastrointest. Liver Physiol. 288 (2005) G1066-G1073